Drug Shortage Report for MAXIDEX
Report ID | 17417 |
Drug Identification Number | 00042579 |
Brand name | MAXIDEX |
Common or Proper name | MAXIDEX OINTMENT 3.5MG |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXAMETHASONE |
Strength(s) | 0.1% |
Dosage form(s) | OINTMENT |
Route of administration | OPHTHALMIC |
Packaging size | 3.5 MG |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2017-07-23 |
Estimated end date | 2017-09-11 |
Actual end date | 2017-09-07 |
Shortage status | Resolved |
Updated date | 2017-09-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-07-27 | English | Compare |
v2 | 2017-07-27 | French | Compare |
v3 | 2017-08-10 | English | Compare |
v4 | 2017-08-10 | French | Compare |
v5 | 2017-08-31 | English | Compare |
v6 | 2017-08-31 | English | Compare |
v7 | 2017-08-31 | French | Compare |
v8 | 2017-09-07 | English | Compare |
v9 | 2017-09-07 | French | Compare |
v10 | 2017-09-07 | English | Compare |
v11 | 2017-09-07 | French | Compare |
v12 | 2017-09-08 | English | Compare |
Showing 1 to 12 of 12